Inogen Hires Michael Bourque to Assume the Role of CFO

Inogen, Inc. (Nasdaq: INGN), a medical technology company specializing in innovative respiratory products for homecare, has announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque, previously Treasurer and CFO of Chase Corporation (formerly NYSE: CCF), currently owned by KKR & Co. Inc., will take over the position from Interim Chief Financial Officer Mike Sergesketter, who will continue in an advisory role during the transition.

Mr. Bourque has been serving as Chief Financial Officer and Treasurer of Chase Corporation since 2021. His prior roles include Chief Financial Officer of Keystone Dental, Senior Vice President, Chief Financial Officer, and Treasurer of Analogic Corporation from 2014 to 2018, and Vice President of Finance for Axcelis Technologies from 2011 to 2014. Bourque holds a bachelor’s degree in accounting from Bentley University.

Kevin Smith, President and CEO of Inogen, expressed excitement about Michael Bourque joining as the new Chief Financial Officer, highlighting his experience in building top-tier finance teams. Smith also extended gratitude to Mike Sergesketter for his interim role, acknowledging his significant contribution and wishing him well in retirement.

In response to his appointment, Michael Bourque stated that he is excited to be joining Inogen at such a pivotal point in the Company’s story.

Have you read?
Character – The Aerodynamics of Leadership.
The Rise of the Inter-Generational CEO: Working with Gen Z eye to eye.
A New Approach to Public Sector Decision Making.
How a CEO Can Best Handle a Crisis.
Redefining Thankfulness: Gratitude Examples for the Forward-Thinking Leader.
Financial Services, Risk Management and Beyond — Tech Entrepreneur, Henna Karna’s Vision for the Future.